CME (CME) Q3 2026 Earnings Call Transcript
CME Group reported Q3 2026 revenue of $1.7B, up 13% YoY, with record market data revenue of $243M. International volume reached 9M contracts/day, up 22% YoY. New products were launched, and cloud migration progress was shared. Adjusted EPS was $3.02, up 13% YoY. The company returned $1B to shareholders. Compute Futures progress depends on CFTC approval.
How this was made

The 30-second read
Why it matters
The earnings beat and aggressive share‑repurchase program suggest near‑term bullish pressure on CME stock, while pending regulatory approvals for new products add uncertainty.
Market read
CME’s strong earnings and product expansion reinforce its market‑leadership, likely influencing other exchange operators and financial‑services equities.
What to watch
Potential regulatory scrutiny of new compute futures and 24/7 crypto products could temper enthusiasm.
Background
CME Group’s Q3 2026 earnings call transcript provides the first public disclosure of its quarterly financial results and product updates.
Ticker impact
CME Group posted Q3 2026 revenue of $1.7 billion, up 13% YoY, and adjusted EPS of $3.02, up 13% YoY.
likely upward pressure as investors price in better‑than‑expected earnings and higher margins
Revenue and EPS beat expectations, record market‑data revenue, and sizable share‑repurchase signal confidence.
Market effects
reinforces strength of financial‑services and exchange‑operator sector
positive bias for US listed exchange stocks
signals continued demand for derivatives and market‑data services worldwide
Counterpoint
If market expectations were already high, the modest revenue growth may disappoint, limiting upside.
Key entities
- companyCME Group
US‑listed exchange operator (ticker CME).
- executiveTerry Duffy
CEO of CME Group, discussed product pipeline.


